Search results
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial
Investing.com· 3 days agoAtea Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics for viral...
No wonder Republicans are afraid of a debate — Donald Trump is barely holding it together at trial
Salon via Yahoo News· 14 hours agoTrump also defended kidnapping children from immigrant families, repeatedly insisted the thousands...
Dow Jones Industrial Average Tops 40000 for the First Time
The Wall Street Journal· 1 day agoDow rose as high as 40051 on Thursday morning before pulling back to close at 39869. It has soared...
Living with ALS at 27: Young Canadian with ALS opens up about life after diagnosis that 'throws your...
Yahoo Canada Style· 1 day agoArchibald says having to quit the military was the worst part of getting diagnosed with ALS....
Analysts reboot Alibaba stock price target after earnings
TheStreet via Yahoo Finance· 2 days agoFor one thing, China's economy has only slowly recovered from the Covid-19 pandemic. A McKinsey &...
Atossa Therapeutics Inc (ATOS) Q1 2024 Earnings: Aligns with Analyst Projections Amidst ...
GuruFocus.com via Yahoo Finance· 4 days agoIts key drug under development, Endoxifen, is currently being evaluated in multiple Phase 2 trials....
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 4 days agoLet's consider two such stocks: Moderna (NASDAQ: MRNA) and DexCom (NASDAQ: DXCM). These two...
Mortgage rates dip lower on positive inflation news, hold at near 7%: Freddie Mac
FOX Business· 9 hours agoMortgage rates topped 7% again this week, but April inflation numbers are a promising step toward...
Trial HIV vaccine triggers elusive and essential antibodies, pointing the way toward a successful...
Medical Xpress· 9 hours agoThe finding, reported May 17 in the journal Cell, not only provides proof that a vaccine can elicit these antibodies to fight diverse strains of HIV, but that it can also ...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 2 days agoGeoVax reported a net loss of $5.9 million for the quarter but remains optimistic about its...